These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10896118)

  • 1. Pyrrolo-quinoline derivatives as potential antineoplastic drugs.
    Ferlin MG; Gatto B; Chiarelotto G; Palumbo M
    Bioorg Med Chem; 2000 Jun; 8(6):1415-22. PubMed ID: 10896118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel pyrrolo[3,2-f]quinolines: synthesis and antiproliferative activity.
    Ferlin MG; Gatto B; Chiarelotto G; Palumbo M
    Bioorg Med Chem; 2001 Jul; 9(7):1843-8. PubMed ID: 11425586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New water soluble pyrroloquinoline derivatives as new potential anticancer agents.
    Ferlin MG; Marzano C; Dalla Via L; Chilin A; Zagotto G; Guiotto A; Moro S
    Bioorg Med Chem; 2005 Aug; 13(15):4733-9. PubMed ID: 15936202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ring-substituted 11-oxo-11H-indeno[1,2-b]quinoline-6-carboxamides with similar patterns of cytotoxicity to the dual topo I/II inhibitor DACA.
    Deady LW; Desneves J; Kaye AJ; Thompson M; Finlay GJ; Baguley BC; Denny WA
    Bioorg Med Chem; 1999 Dec; 7(12):2801-9. PubMed ID: 10658584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and inhibitory activity of novel tri- and tetracyclic quinolines against topoisomerases.
    Sui Z; Altom J; Nguyen VN; Fernandez J; Bernstein JI; Hiliard JJ; Barrett JF; Podlogar BL; Ohemeng KA
    Bioorg Med Chem; 1998 Jun; 6(6):735-42. PubMed ID: 9681139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and cytotoxicity of 2-methyl-1-substituted-imidazo [4,5-g]quinoline-4,9-dione and 7,8-dihydro-10H-[1,4]oxazino[3',4':2,3]imidazo[4,5-g]quinoline-5,12-dio ne derivatives.
    Suh ME; Kang MJ; Yoo HW; Park SY; Lee CO
    Bioorg Med Chem; 2000 Aug; 8(8):2079-83. PubMed ID: 11003153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitumor properties of N-[2-(dimethylamino)ethyl]carboxamide derivatives of fused tetracyclic quinolines and quinoxalines: a new class of putative topoisomerase inhibitors.
    Deady LW; Kaye AJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1997 Jun; 40(13):2040-6. PubMed ID: 9207945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methoxy- and methyl-, methoxy-5,6,11-trimethyl-6H-indolo [2,3-b]quinolinium derivatives as novel cytotoxic agents and DNA topoisomerase II inhibitors.
    Kaczmarek L; Peczyńska-Czoch W; Opolski A; Wietrzyk J; Marcinkowska E; Boratyński J; Osiadacz J
    Anticancer Res; 1998; 18(4C):3133-8. PubMed ID: 9713522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivatives.
    Chen YL; Chen IL; Wang TC; Han CH; Tzeng CC
    Eur J Med Chem; 2005 Sep; 40(9):928-34. PubMed ID: 15913847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
    Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
    Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, cytotoxic activity, DNA topoisomerase-II inhibition, molecular modeling and structure-activity relationship of 9-anilinothiazolo[5,4-b]quinoline derivatives.
    Loza-Mejía MA; Olvera-Vázquez S; Maldonado-Hernández K; Guadarrama-Salgado T; González-Sánchez I; Rodríguez-Hernández F; Solano JD; Rodríguez-Sotres R; Lira-Rocha A
    Bioorg Med Chem; 2009 May; 17(9):3266-77. PubMed ID: 19364657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolino[3,4-b]quinoxalines and pyridazino[4,3-c]quinoline derivatives: Synthesis, inhibition of topoisomerase IIα, G-quadruplex binding and cytotoxic properties.
    Palluotto F; Sosic A; Pinato O; Zoidis G; Catto M; Sissi C; Gatto B; Carotti A
    Eur J Med Chem; 2016 Nov; 123():704-717. PubMed ID: 27521587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bis(phenazine-1-carboxamides): structure-activity relationships for a new class of dual topoisomerase I/II-directed anticancer drugs.
    Spicer JA; Gamage SA; Rewcastle GW; Finlay GJ; Bridewell DJ; Baguley BC; Denny WA
    J Med Chem; 2000 Apr; 43(7):1350-8. PubMed ID: 10753472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of substituted indeno[1,2-b]quinoline-6-carboxamides, [1]benzothieno[3,2-b]quinoline-4-carboxamides and 10H-quindoline-4-carboxamides: evaluation of structure-activity relationships for cytotoxicity.
    Chen J; Deady LW; Desneves J; Kaye AJ; Finlay GJ; Baguley BC; Denny WA
    Bioorg Med Chem; 2000 Oct; 8(10):2461-6. PubMed ID: 11058041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based hybridization, synthesis and biological evaluation of novel tetracyclic heterocyclic azathioxanthone analogues as potential antitumor agents.
    Chen TC; Wu CL; Lee CC; Chen CL; Yu DS; Huang HS
    Eur J Med Chem; 2015 Oct; 103():615-27. PubMed ID: 25799376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationship of 4-substituted 2-(2-acetyloxyethyl)-8-(morpholine-4-sulfonyl)pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors.
    Kravchenko DV; Kuzovkova YA; Kysil VM; Tkachenko SE; Maliarchouk S; Okun IM; Balakin KV; Ivachtchenko AV
    J Med Chem; 2005 Jun; 48(11):3680-3. PubMed ID: 15916416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, cytotoxicity, DNA interaction and topoisomerase II inhibition properties of tetrahydropyrrolo[3,4-a]carbazole-1,3-dione and tetrahydropyrido-[3,2-b]pyrrolo[3,4-g]indole-1,3-dione derivatives.
    Joseph B; Facompré M; Da Costa H; Routier S; Mérour JY; Colson P; Houssier C; Bailly C
    Bioorg Med Chem; 2001 Jun; 9(6):1533-41. PubMed ID: 11408172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivatives: DNA topoisomerase II inhibitors.
    Kaczmarek L; Peczyńska-Czoch W; Osiadacz J; Mordarski M; Sokalski WA; Boratyński J; Marcinkowska E; Glazman-Kuśnierczyk H; Radzikowski C
    Bioorg Med Chem; 1999 Nov; 7(11):2457-64. PubMed ID: 10632055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.
    Luniewski W; Wietrzyk J; Godlewska J; Switalska M; Piskozub M; Peczynska-Czoch W; Kaczmarek L
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6103-7. PubMed ID: 22944121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pyrrolo-quinoline derivatives as potent inhibitors for PI3-kinase related kinases.
    Peng H; Kim DI; Sarkaria JN; Cho YS; Abraham RT; Zalkow LH
    Bioorg Med Chem; 2002 Jan; 10(1):167-74. PubMed ID: 11738618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.